Evaluation of the ability of an organic derivative of ruthenium(II) to reinforce the cytotoxicity of fast neutron against malignant cells in culture

Fiche publication


Date publication

janvier 2008

Auteurs

Membres identifiés du Cancéropôle Est :
Dr GAIDDON Christian, Dr LOEFFLER Jean-Philippe


Tous les auteurs :
Leyva L, Malek F, Benzina S, Denis JM, Gueulette J, Dufour P, Gaiddon C, Loeffler JP, Sirlin C, Pfeffer M, Bischoff P

Résumé

The effect of combining RDC-11 (a new ruthenium organometallic complex) and fast neutrons (high-LET radiations) has been evaluated in RDM4 and U-87 tumor cell lines. After co-treatment, a substantial reduction of cell growth was recorded, which appears not to be correlated with the induction of apoptosis.

Référence

Lett Drug Des Discov. 2008 Jan;5(1):1-6